Definitive Healthcare Corp (NASDAQ:DH) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET
Company Participants
David Samuels - Chief Legal Officer
Robert Musslewhite - President, CEO & Director
Jason Krantz - Founder & Executive Chairman
Richard Booth - CFO
Conference Call Participants
Craig Hettenbach - Morgan Stanley
Maxi Ma - Deutsche Bank
David Grossman - Stifel, Nicolaus & Company
Jonathan Yong - Crédit Suisse
Saket Kalia - Barclays Bank
Ryan MacDonald - Needham & Company
Operator
Good day, and welcome to the Definitive Healthcare Conference Call. [Operator Instructions]. Please note, this event is being recorded. I would now like to turn the conference over to Mr. David Samuels, Chief Legal Officer. Please go ahead.
David Samuels
Good morning, and thank you for joining us today to review Definitive Healthcare Second Quarter 2020 Financial Results. Joining the call today are Robert Musslewhite, Definitive Healthcare's CEO; Jason Krantz, Definitive Healthcare's Founder and Executive Chair; and Rick Booth, Definitive Healthcare's Chief Financial Officer.
During the call, we will make forward-looking statements, including, but not limited to, statements relating to our markets and future growth opportunities, the benefits of our health care commercial intelligence solutions, our competitive position, customer behaviors, our financial guidance, our planned investments and the anticipated impact from the COVID-19 pandemic on our business and results of operations as well as on our clients, the health care industry generally and the macroeconomic environment.
Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the Risk Factors section of our filings with the SEC. Actual results may differ materially from forward-looking statements. The company undertakes no obligations to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law. For more information, please refer to the cautionary statements included in the earnings release that was just posted to the Investor Relations portion of our website.
Additionally, we will discuss non-GAAP financial performance measures on this conference call. References on this call to profitability are on an adjusted EBITDA basis. Please refer to the tables in our earnings release on the Investor Relations portion of our website for a reconciliation of these measures to the most directly comparable GAAP financial measures.
With that, I'd like to turn the call over to Robert.